Broadfoot Jill Marie bought ATYR
February 3, 2026 · Form 4 insider transaction
Broadfoot Jill Marie bought 3,750 shares of aTyr Pharma, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
3,750
Price
N/A
Total value
N/A
InsiderBroadfoot Jill Marie
RoleDirector
CompanyaTyr Pharma, Inc. (ATYR)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 3, 2026
Filing dateFebruary 4, 2026
Shares owned after38,854
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 3, 2022.; Restricted stock units convert into common stock on a one-for-one basis.